Studies on antitumor components of Collybia confluens

S. H. Kim, J. S. Kim, M. R. Jin, E. C. Choi, B. K. Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

To find antitumor components from higher fungi, the mycelia of Collybia confluens (Pers. ex Fr.) Kummer were cultured in artificial media. For efficient production of the mycelia, the influences of various modifications of culture conditions were examined. A water-soluble protein-bound polysaccharide fraction, Fr. A, was obtained frcm the mycelia by hot water extraction. When Fr. A was purified and fractionated by DEAE-cellulose and Sephadex G-200 gel filtration chromatographies into four fractions which were designated B, C, C-I and C-II. The tumor inhibition ratios of these fractions ranged from 46% to 75% against the solid forms of sarcoma 180 in ICR mice at doses of 20 and 50 mg/kg/day when given intraperitoneally. Especially, Fr. C which was named Collyban (CB) exhibited a marked life-prolonging effect of the mice against ascitic forms of sarcoma 180 at a dose of 50 mg via i.p. administration. To extend spectra of the antitumor activities and eliminate the effects of allograft rejection, the characterisation of antitumor effects of CB was performed in syngeneic host-tumor systems. It did not show any antitumor activity against L1210 murine leukemia in CD2F1 mice but prolonged their life span against ascitic forms of MM46 carcinoma in C3H/He mice. Also it exhibited antitumor activity against human cervical cancer HeLa cells that were xenografted into nude mice having BALB/c genetic backgrounds by the i.p. injection at a dose of 100 mg/kg/day. In order to characterize the antitumor components, CB was examined by chemical analysis. It was acidic protein-bound polysaccharides composed of 31% polysaccharide, 27% protein and 3% hexosamine. CB was fractionated into two fractions, Fr. C-I (M.W.: 500 Kd) and Fr. C-II (M.W.: 30 and 8 Kd) by Sephadex G-200 gel filtration chromatography.

Original languageEnglish (US)
Pages (from-to)267-281
Number of pages15
JournalKorean Journal of Pharmacognosy
Volume24
Issue number4
StatePublished - Dec 1 1993
Externally publishedYes

Fingerprint

Mycelium
Sarcoma 180
Polysaccharides
Gel Chromatography
Hexosamines
Leukemia L1210
DEAE-Dextran
DEAE-Cellulose
Inbred ICR Mouse
Proteins
Water
Inbred C3H Mouse
HeLa Cells
Nude Mice
Human Activities
Uterine Cervical Neoplasms
Allografts
Neoplasms
Fungi
Carcinoma

Keywords

  • antitumor component
  • basidomycetes
  • Collyban
  • Collybia confluens
  • cultured mycelia
  • HeLa cell
  • immunomodulator
  • protein-bound polysaccharides

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Kim, S. H., Kim, J. S., Jin, M. R., Choi, E. C., & Kim, B. K. (1993). Studies on antitumor components of Collybia confluens. Korean Journal of Pharmacognosy, 24(4), 267-281.

Studies on antitumor components of Collybia confluens. / Kim, S. H.; Kim, J. S.; Jin, M. R.; Choi, E. C.; Kim, B. K.

In: Korean Journal of Pharmacognosy, Vol. 24, No. 4, 01.12.1993, p. 267-281.

Research output: Contribution to journalArticle

Kim, SH, Kim, JS, Jin, MR, Choi, EC & Kim, BK 1993, 'Studies on antitumor components of Collybia confluens', Korean Journal of Pharmacognosy, vol. 24, no. 4, pp. 267-281.
Kim, S. H. ; Kim, J. S. ; Jin, M. R. ; Choi, E. C. ; Kim, B. K. / Studies on antitumor components of Collybia confluens. In: Korean Journal of Pharmacognosy. 1993 ; Vol. 24, No. 4. pp. 267-281.
@article{0d1ac94fa044478cb2b4326453eb3782,
title = "Studies on antitumor components of Collybia confluens",
abstract = "To find antitumor components from higher fungi, the mycelia of Collybia confluens (Pers. ex Fr.) Kummer were cultured in artificial media. For efficient production of the mycelia, the influences of various modifications of culture conditions were examined. A water-soluble protein-bound polysaccharide fraction, Fr. A, was obtained frcm the mycelia by hot water extraction. When Fr. A was purified and fractionated by DEAE-cellulose and Sephadex G-200 gel filtration chromatographies into four fractions which were designated B, C, C-I and C-II. The tumor inhibition ratios of these fractions ranged from 46{\%} to 75{\%} against the solid forms of sarcoma 180 in ICR mice at doses of 20 and 50 mg/kg/day when given intraperitoneally. Especially, Fr. C which was named Collyban (CB) exhibited a marked life-prolonging effect of the mice against ascitic forms of sarcoma 180 at a dose of 50 mg via i.p. administration. To extend spectra of the antitumor activities and eliminate the effects of allograft rejection, the characterisation of antitumor effects of CB was performed in syngeneic host-tumor systems. It did not show any antitumor activity against L1210 murine leukemia in CD2F1 mice but prolonged their life span against ascitic forms of MM46 carcinoma in C3H/He mice. Also it exhibited antitumor activity against human cervical cancer HeLa cells that were xenografted into nude mice having BALB/c genetic backgrounds by the i.p. injection at a dose of 100 mg/kg/day. In order to characterize the antitumor components, CB was examined by chemical analysis. It was acidic protein-bound polysaccharides composed of 31{\%} polysaccharide, 27{\%} protein and 3{\%} hexosamine. CB was fractionated into two fractions, Fr. C-I (M.W.: 500 Kd) and Fr. C-II (M.W.: 30 and 8 Kd) by Sephadex G-200 gel filtration chromatography.",
keywords = "antitumor component, basidomycetes, Collyban, Collybia confluens, cultured mycelia, HeLa cell, immunomodulator, protein-bound polysaccharides",
author = "Kim, {S. H.} and Kim, {J. S.} and Jin, {M. R.} and Choi, {E. C.} and Kim, {B. K.}",
year = "1993",
month = "12",
day = "1",
language = "English (US)",
volume = "24",
pages = "267--281",
journal = "Korean Journal of Pharmacognosy",
issn = "0253-3073",
publisher = "Korean Society of Pharmacognosy",
number = "4",

}

TY - JOUR

T1 - Studies on antitumor components of Collybia confluens

AU - Kim, S. H.

AU - Kim, J. S.

AU - Jin, M. R.

AU - Choi, E. C.

AU - Kim, B. K.

PY - 1993/12/1

Y1 - 1993/12/1

N2 - To find antitumor components from higher fungi, the mycelia of Collybia confluens (Pers. ex Fr.) Kummer were cultured in artificial media. For efficient production of the mycelia, the influences of various modifications of culture conditions were examined. A water-soluble protein-bound polysaccharide fraction, Fr. A, was obtained frcm the mycelia by hot water extraction. When Fr. A was purified and fractionated by DEAE-cellulose and Sephadex G-200 gel filtration chromatographies into four fractions which were designated B, C, C-I and C-II. The tumor inhibition ratios of these fractions ranged from 46% to 75% against the solid forms of sarcoma 180 in ICR mice at doses of 20 and 50 mg/kg/day when given intraperitoneally. Especially, Fr. C which was named Collyban (CB) exhibited a marked life-prolonging effect of the mice against ascitic forms of sarcoma 180 at a dose of 50 mg via i.p. administration. To extend spectra of the antitumor activities and eliminate the effects of allograft rejection, the characterisation of antitumor effects of CB was performed in syngeneic host-tumor systems. It did not show any antitumor activity against L1210 murine leukemia in CD2F1 mice but prolonged their life span against ascitic forms of MM46 carcinoma in C3H/He mice. Also it exhibited antitumor activity against human cervical cancer HeLa cells that were xenografted into nude mice having BALB/c genetic backgrounds by the i.p. injection at a dose of 100 mg/kg/day. In order to characterize the antitumor components, CB was examined by chemical analysis. It was acidic protein-bound polysaccharides composed of 31% polysaccharide, 27% protein and 3% hexosamine. CB was fractionated into two fractions, Fr. C-I (M.W.: 500 Kd) and Fr. C-II (M.W.: 30 and 8 Kd) by Sephadex G-200 gel filtration chromatography.

AB - To find antitumor components from higher fungi, the mycelia of Collybia confluens (Pers. ex Fr.) Kummer were cultured in artificial media. For efficient production of the mycelia, the influences of various modifications of culture conditions were examined. A water-soluble protein-bound polysaccharide fraction, Fr. A, was obtained frcm the mycelia by hot water extraction. When Fr. A was purified and fractionated by DEAE-cellulose and Sephadex G-200 gel filtration chromatographies into four fractions which were designated B, C, C-I and C-II. The tumor inhibition ratios of these fractions ranged from 46% to 75% against the solid forms of sarcoma 180 in ICR mice at doses of 20 and 50 mg/kg/day when given intraperitoneally. Especially, Fr. C which was named Collyban (CB) exhibited a marked life-prolonging effect of the mice against ascitic forms of sarcoma 180 at a dose of 50 mg via i.p. administration. To extend spectra of the antitumor activities and eliminate the effects of allograft rejection, the characterisation of antitumor effects of CB was performed in syngeneic host-tumor systems. It did not show any antitumor activity against L1210 murine leukemia in CD2F1 mice but prolonged their life span against ascitic forms of MM46 carcinoma in C3H/He mice. Also it exhibited antitumor activity against human cervical cancer HeLa cells that were xenografted into nude mice having BALB/c genetic backgrounds by the i.p. injection at a dose of 100 mg/kg/day. In order to characterize the antitumor components, CB was examined by chemical analysis. It was acidic protein-bound polysaccharides composed of 31% polysaccharide, 27% protein and 3% hexosamine. CB was fractionated into two fractions, Fr. C-I (M.W.: 500 Kd) and Fr. C-II (M.W.: 30 and 8 Kd) by Sephadex G-200 gel filtration chromatography.

KW - antitumor component

KW - basidomycetes

KW - Collyban

KW - Collybia confluens

KW - cultured mycelia

KW - HeLa cell

KW - immunomodulator

KW - protein-bound polysaccharides

UR - http://www.scopus.com/inward/record.url?scp=0027731912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027731912&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 267

EP - 281

JO - Korean Journal of Pharmacognosy

JF - Korean Journal of Pharmacognosy

SN - 0253-3073

IS - 4

ER -